Pharmacare News Bulletins

Nova Scotia Pharmacare

Pharmacare News Bulletins

The Pharmacare News Bulletins, which are mailed to pharmacies and physicians, are listed below. They are an important source of information as they provide timely information on recent changes to the Pharmacare Programs.

Please continue to refer to the Pharmacare News Bulletins to stay current with Formulary and Pharmacare Program updates.

Pharmacare News: Pharmacists Edition

Latest Issue

October 2017 Vol. 17 – 04
Mifegymiso (mifepristone and misoprostol), Basaglar (insulin glargine), Brenzys (etanercept); Influenza vaccine; Delisted Products: Butalbital-Containing Products

Previous Issues

August 2017 Vol. 17 – 03
New Exception Status Benefits
Forxiga (dapagliflozin); Xigduo (dapagliflozin and metformin hydrochloride); Criteria Updates: Antipsychotic Medications

April 2017 Vol. 17 – 02
Expanded Coverage for Chronic Hepatitis C; Minor Ailment Demonstration Project; Criteria Updates: Buprenorphine/Naloxone

January 2017 Vol. 17 - 01
Criteria Updates: Biphentin, Concerta and generics (methylphenidate ER), Vyvanse; Notification of Quinine Delisting; Medical Assistance in Dying: Adjudication of Claims

Pharmacare News: Physicians Edition

Latest Issue

August 2017 Vol. 17 – 03
New Exception Status Benefits: Forxiga (dapagliflozin); Xigduo (dapagliflozin and metformin hydrochloride); Criteria Updates: Antipsychotic Medications

Previous Issues

April 2017 Vol. 17 – 02
Expanded Coverage for Chronic Hepatitis C; Criteria Updates: Buprenorphine/Naloxone

January 2017 Vol. 17 - 01
Criteria Updates: Biphentin, Concerta and generics (methylphenidate ER), Vyvanse; Notification of Quinine Delisting